For specialists

The effectiveness of the use of ciprofloxacin and tobramycin in the treatment of neonatal dacryocystitis and acute bacterial conjunctivitis in young children
Published in the journal «Ophthalmology Journal» № 6’2012
Dynamics of indicators of video laryngostroboscopy during complex treatment of patients with persistent functional dysphonias, which are accompanied by pronounced hypotonia of the vocal apparatus
Published in a journal «Journal of Ear, Nose and Throat Diseases» № 6’ 2012
Energy-dynamic correction of chronic heart failure in arterial hypertension of renal origin
Published in the journal «Arterial Hypertension» № 6(26) ’2012
The drug of high metabolic activity Kokarnit in the treatment of diabetic autonomic neuropathy of the heart
Published in the journal «Medical Business» № 3-4 ’2012
Study of the sensitivity of microflora during eye burns to antibacterial drugs «Floximed» and «Tobrimed»
Published in a journal «Ophthalmological Journal» № 4’2012
New risk factors and new opportunities for the prevention of acid-related diseases
Published in thematic issue «Gastroenterology. Hepatology. Coloproctology» № 4 (26) ’2012
Use of the drug Cocarnit in patients after endoprosthetics of the hip and knee joints
Published in a journal «Trauma» Vol 13 № 4 ’2012
The effectiveness of drugs ciprofloxacin and tobramycin in the treatment of traumatic keratitis
Published in the journal «Ophthalmology Journal» № 3’2012
Study of the analgesic effect of diclofenac sodium eye drops during panretinal laser coagulation in patients with diabetic retinopathy
Published in a journal «Ophthalmological Journal» № 3’2012
The effectiveness of using ciprofloxacin, tobramycin and diclofenac sodium in the treatment of exogenous keratitis
Published in the journal «Ophthalmological journal» № 3’2012

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design